Back to 
Boston Trust Walden Corp
Boston Trust Walden Corp
ANIK
Showing 0 of 10 quarters
Position history for Boston Trust Walden Corp's holdings in ANIKA THERAPEUTICS INC
No. Boston Trust Walden exited its ANIK (Anika Therapeutics) position in Q2 2021. Its Q1 2021 13F listed 375,070 shares worth $15.3M. Boston Trust Walden already held ANIK in its Q1 2019 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.